281 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

ATUM Competitors or Alternatives

ATUM's top competitors include Adaptyv, Integral Molecular and Anova-plus.

Unlock 11 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

ATUM's company profile

Jeremy Minshull

President & CEO

90/100
25 - 100
$0
$5M - 25M
  • $0
    $5M - 25M
  • 25 - 100
    $0
  • $5M - 25M
  • 90/100
  • 25 - 100
  • $0
  • $5M - 25M
View ProfileView
1
ATUM's Competitor - Adaptyv logo

Julian Englert

Co-Founder

90/100
1 - 25
$3.1M
$100K - 5M
  • $3.1M
    $100K - 5M
  • 1 - 25
    $3.1M
  • $100K - 5M
  • 90/100
  • 1 - 25
  • $3.1M
  • $100K - 5M
View ProfileView
2
ATUM's Competitor - Integral Molecular logo

Benjamin Doranz

President & CEO

90/100
100 - 250
$7.4M
$5M - 25M
  • $7.4M
    $5M - 25M
  • 100 - 250
    $7.4M
  • $5M - 25M
  • 90/100
  • 100 - 250
  • $7.4M
  • $5M - 25M
View ProfileView
3
ATUM's Competitor - Anova-plus logo

Marc Masson

President

70/100
25 - 100
- -
$100K - 5M
  • - -
    $100K - 5M
  • 25 - 100
    - -
  • $100K - 5M
  • 70/100
  • 25 - 100
  • - -
  • $100K - 5M
View ProfileView
4
ATUM's Competitor - Agios logo

Brian Goff

CEO

85/100
390
$226M
$37M
  • $226M
    $37M
  • 390
    $226M
  • $37M
  • 85/100
  • 390
  • $226M
  • $37M
View ProfileView
5
ATUM's Competitor - BioVision logo

Gordon Yan

Co-Founder & CEO

87/100
100 - 250
- -
$25M - 100M
  • - -
    $25M - 100M
  • 100 - 250
    - -
  • $25M - 100M
  • 87/100
  • 100 - 250
  • - -
  • $25M - 100M
View ProfileView
ATUM's top 14 competitors are Adaptyv, Integral Molecular, Anova-plus, ResearchDx, Agios, BioVision, ITI, CALIXAR, BioLegend, Aviscera Bioscience, Mayflower Bioscience, Aimmune, DBV Technologies and ESSA. Together they have raised over 1.6B between their estimated 2.2K employees. ATUM's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 34.9M. ATUM has 70 employees and is ranked 8th among it's top 10 competitors. The top 10 competitors average 153.

ATUM VS Adaptyv

Adaptyv is perceived as one of ATUM's biggest rivals. Adaptyv's headquarters is in Lausanne, Geneva, and was founded in 2020. Adaptyv operates in the Biotechnology industry. Adaptyv generates 12% of ATUM's revenue.

ATUM VS Integral Molecular

Integral Molecular has been one of ATUM's top competitors. Integral Molecular is a Private company that was founded in 2001 in Philadelphia, Pennsylvania. Integral Molecular operates in the Biotechnology industry. Compared to ATUM, Integral Molecular has 130 more employees.

Looking for similar companies to ATUM?

Similar Companies

Biotechnology companies in Newark

See 39 companies 
Biotechnology companies in San Francisco Bay Area

See 1,319 companies 
Pharmaceuticals & Biotechnology companies in Newark

See 58 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 1,673 companies 
Companies in Newark with revenue in $5.0-25M range

See 1,913 companies 
Companies in Newark with employees in 25-100 range

See 2,404 companies 
Biotechnology companies in California

See 3,096 companies 
Biotechnology companies with revenue in $5.0-25M range

See 3,618 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,183 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for ATUM and ATUM's Competitors

May 2, 2025Seeking Alpha
April 30, 2025FinanzNachrichten
Châtillon, France, April 30, 2025 DBV Technologies Reports First Quarter 2025 Financial Results DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - ...
May 1, 2025Marketscreener
Agios Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported revenue w...
May 2, 2025StreetInsider
CAMBRIDGE, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pionee...
May 1, 2025Owler
Agios’s Trailing Twelve Months revenue changed from $36.50M in Dec 2024 to $37.03M in Mar 2025 increasing 1.5% in this time period....
May 1, 2025Owler
DBV Technologies’s Trailing Twelve Months revenue changed from $4.15M in Dec 2024 to $3.50M in Mar 2025 decreasing 15.8% in this time period....
April 30, 2025Benzinga
Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro trade...

Frequently Asked Questions about ATUM

  1. Who are ATUM's top competitors?

    ATUM's top 3 competitors are Adaptyv, Integral Molecular, Anova-plus.

  2. Who is similar to ATUM?

    Adaptyv is the most similar to ATUM. Integral Molecular and Anova-plus are also similar to ATUM.

  1. Are ATUM and Adaptyv competitors?

    Yes, Adaptyv is one of ATUM’s top competitors.